+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hormone Drug"

From
From
From
From
From
Type 1 Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
Growth Hormone Deficiency (GHD) - Pipeline Insight, 2024 - Product Thumbnail Image

Growth Hormone Deficiency (GHD) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Octreotide Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Octreotide Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2024 - Product Thumbnail Image

Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hypertriglyceridemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Acromegaly - Pipeline Insight, 2024 - Product Thumbnail Image

Acromegaly - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Somatotropin deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Somatotropin deficiency - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Hypogonadism - Pipeline Insight, 2024 - Product Thumbnail Image

Hypogonadism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hypoparathyroidism - Pipeline Insight, 2024 - Product Thumbnail Image

Hypoparathyroidism - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Prader-Willi Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Prader-Willi Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Prediabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Prediabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Porphyria - Pipeline Insight, 2024 - Product Thumbnail Image

Porphyria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 65 Pages
  • Global
From
Cushing's Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Cushing's Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Pheochromocytoma - Pipeline Insight, 2024 - Product Thumbnail Image

Pheochromocytoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Loading Indicator

The Hormone Drug market is a subset of the biotechnology industry that focuses on the development and production of drugs that target hormones. These drugs are used to treat a variety of conditions, including diabetes, obesity, infertility, and menopause. Hormone drugs are typically administered through injections, patches, or pills, and are designed to mimic the body's natural hormones. The hormone drug market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing ones. Additionally, many companies are investing in research and development to create more effective treatments. Notable companies in the hormone drug market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more